1pwc

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1pwc" size="450" color="white" frame="true" align="right" spinBox="true" caption="1pwc, resolution 1.10&Aring;" /> '''penicilloyl acyl enz...)
Line 1: Line 1:
-
[[Image:1pwc.gif|left|200px]]<br /><applet load="1pwc" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1pwc.gif|left|200px]]<br /><applet load="1pwc" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1pwc, resolution 1.10&Aring;" />
caption="1pwc, resolution 1.10&Aring;" />
'''penicilloyl acyl enzyme complex of the Streptomyces R61 DD-peptidase with penicillin G'''<br />
'''penicilloyl acyl enzyme complex of the Streptomyces R61 DD-peptidase with penicillin G'''<br />
==Overview==
==Overview==
-
The bacterial D-alanyl-D-alanine transpeptidases (DD-peptidases) are the, killing targets of beta-lactams, the most important clinical defense, against bacterial infections. However, due to the constant development of, antibiotic-resistance mechanisms by bacteria, there is an ever-present, need for new, more effective antimicrobial drugs. While enormous numbers, of beta-lactam compounds have been tested for antibiotic activity in over, 50 years of research, the success of a beta-lactam structure in terms of, antibiotic activity remains unpredictable. Tipper and Strominger suggested, long ago that beta-lactams inhibit DD-peptidases because they mimic the, D-alanyl-D-alanine motif of the peptidoglycan substrate of these enzymes., They also predicted that beta-lactams having a peptidoglycan-mimetic, side-chain might be better antibiotics than their non-specific, counterparts, but decades of research have not provided any evidence for, this. We have recently described two such novel beta-lactams. The first is, a penicillin having the glycyl-L-alpha-amino-epsilon-pimelyl side-chain of, Streptomyces strain R61 peptidoglycan, making it the "perfect penicillin", for this organism. The other is a cephalosporin with the same side-chain., Here, we describe the X-ray crystal structures of the perfect penicillin, in non-covalent and covalent complexes with the Streptomyces R61, DD-peptidase. The structure of the non-covalent enzyme-inhibitor complex, is the first such complex to be trapped crystallographically with a, DD-peptidase. In addition, the covalent complex of the, peptidyl-cephalosporin with the R61 DD-peptidase is described. Finally, two covalent complexes with the traditional beta-lactams benzylpenicillin, and cephalosporin C were determined for comparison with the peptidyl, beta-lactams. These structures, together with relevant kinetics data, support Tipper and Strominger's assertion that peptidoglycan-mimetic, side-chains should improve beta-lactams as inhibitors of DD-peptidases.
+
The bacterial D-alanyl-D-alanine transpeptidases (DD-peptidases) are the killing targets of beta-lactams, the most important clinical defense against bacterial infections. However, due to the constant development of antibiotic-resistance mechanisms by bacteria, there is an ever-present need for new, more effective antimicrobial drugs. While enormous numbers of beta-lactam compounds have been tested for antibiotic activity in over 50 years of research, the success of a beta-lactam structure in terms of antibiotic activity remains unpredictable. Tipper and Strominger suggested long ago that beta-lactams inhibit DD-peptidases because they mimic the D-alanyl-D-alanine motif of the peptidoglycan substrate of these enzymes. They also predicted that beta-lactams having a peptidoglycan-mimetic side-chain might be better antibiotics than their non-specific counterparts, but decades of research have not provided any evidence for this. We have recently described two such novel beta-lactams. The first is a penicillin having the glycyl-L-alpha-amino-epsilon-pimelyl side-chain of Streptomyces strain R61 peptidoglycan, making it the "perfect penicillin" for this organism. The other is a cephalosporin with the same side-chain. Here, we describe the X-ray crystal structures of the perfect penicillin in non-covalent and covalent complexes with the Streptomyces R61 DD-peptidase. The structure of the non-covalent enzyme-inhibitor complex is the first such complex to be trapped crystallographically with a DD-peptidase. In addition, the covalent complex of the peptidyl-cephalosporin with the R61 DD-peptidase is described. Finally, two covalent complexes with the traditional beta-lactams benzylpenicillin and cephalosporin C were determined for comparison with the peptidyl beta-lactams. These structures, together with relevant kinetics data, support Tipper and Strominger's assertion that peptidoglycan-mimetic side-chains should improve beta-lactams as inhibitors of DD-peptidases.
==About this Structure==
==About this Structure==
-
1PWC is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Streptomyces_sp. Streptomyces sp.] with PNM as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Serine-type_D-Ala-D-Ala_carboxypeptidase Serine-type D-Ala-D-Ala carboxypeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.16.4 3.4.16.4] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1PWC OCA].
+
1PWC is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Streptomyces_sp. Streptomyces sp.] with <scene name='pdbligand=PNM:'>PNM</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Serine-type_D-Ala-D-Ala_carboxypeptidase Serine-type D-Ala-D-Ala carboxypeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.16.4 3.4.16.4] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1PWC OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Streptomyces sp.]]
[[Category: Streptomyces sp.]]
-
[[Category: Josephine, H.R.]]
+
[[Category: Josephine, H R.]]
-
[[Category: Kelly, J.A.]]
+
[[Category: Kelly, J A.]]
-
[[Category: Pratt, R.F.]]
+
[[Category: Pratt, R F.]]
-
[[Category: Silvaggi, N.R.]]
+
[[Category: Silvaggi, N R.]]
[[Category: PNM]]
[[Category: PNM]]
[[Category: antibiotics]]
[[Category: antibiotics]]
Line 25: Line 25:
[[Category: peptidoglycan]]
[[Category: peptidoglycan]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 00:10:48 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:33:14 2008''

Revision as of 12:33, 21 February 2008


1pwc, resolution 1.10Å

Drag the structure with the mouse to rotate

penicilloyl acyl enzyme complex of the Streptomyces R61 DD-peptidase with penicillin G

Overview

The bacterial D-alanyl-D-alanine transpeptidases (DD-peptidases) are the killing targets of beta-lactams, the most important clinical defense against bacterial infections. However, due to the constant development of antibiotic-resistance mechanisms by bacteria, there is an ever-present need for new, more effective antimicrobial drugs. While enormous numbers of beta-lactam compounds have been tested for antibiotic activity in over 50 years of research, the success of a beta-lactam structure in terms of antibiotic activity remains unpredictable. Tipper and Strominger suggested long ago that beta-lactams inhibit DD-peptidases because they mimic the D-alanyl-D-alanine motif of the peptidoglycan substrate of these enzymes. They also predicted that beta-lactams having a peptidoglycan-mimetic side-chain might be better antibiotics than their non-specific counterparts, but decades of research have not provided any evidence for this. We have recently described two such novel beta-lactams. The first is a penicillin having the glycyl-L-alpha-amino-epsilon-pimelyl side-chain of Streptomyces strain R61 peptidoglycan, making it the "perfect penicillin" for this organism. The other is a cephalosporin with the same side-chain. Here, we describe the X-ray crystal structures of the perfect penicillin in non-covalent and covalent complexes with the Streptomyces R61 DD-peptidase. The structure of the non-covalent enzyme-inhibitor complex is the first such complex to be trapped crystallographically with a DD-peptidase. In addition, the covalent complex of the peptidyl-cephalosporin with the R61 DD-peptidase is described. Finally, two covalent complexes with the traditional beta-lactams benzylpenicillin and cephalosporin C were determined for comparison with the peptidyl beta-lactams. These structures, together with relevant kinetics data, support Tipper and Strominger's assertion that peptidoglycan-mimetic side-chains should improve beta-lactams as inhibitors of DD-peptidases.

About this Structure

1PWC is a Single protein structure of sequence from Streptomyces sp. with as ligand. Active as Serine-type D-Ala-D-Ala carboxypeptidase, with EC number 3.4.16.4 Full crystallographic information is available from OCA.

Reference

Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin"., Silvaggi NR, Josephine HR, Kuzin AP, Nagarajan R, Pratt RF, Kelly JA, J Mol Biol. 2005 Jan 21;345(3):521-33. PMID:15581896

Page seeded by OCA on Thu Feb 21 14:33:14 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools